Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05140915 · ClinicalTrials.gov registry record · NA
Vaper to Vaper: A Multimodal Mobile Peer Driven Intervention to Support Adolescents in Quitting Vaping
A NA study of Vaping and E-cigarette Use, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
- 1
- Study location
NCT05140915: Completed NA study of Vaping and E-cigarette Use, sponsored by University of Massachusetts, Worcester.
NCT05140915 is a NA study of Vaping and E-cigarette Use that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 71 participants, below the 757-participant average among 18 other Vaping trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05140915, a NA study of Vaping and E-cigarette Use, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
- 1
- Study location
Study Summary
The dramatic increase in the use of e-cigarettes among U.S. adolescents has been called a national epidemic, with more adolescents now using e-cigarettes than traditional cigarettes. The high amounts of nicotine in e-cigarettes harm adolescents and put them at greater risk of becoming traditional cigarette smokers. The investigators propose to develop Vaper-to-Vaper (V2V), a suite of mobile peer driven tools including peer texting and coaching based on lessons learned in the investigators' prior tobacco intervention work, to engage and help adolescents use strategies to manage cravings and successfully quit.
Primary Outcome
Investigators will assess the number of those screened, eligible, and consented who remain active in the program at 3 months.
Conditions Studied
Interventions
- BEHAVIORAL Gamification
- BEHAVIORAL Peer Messaging
- BEHAVIORAL Peer Coaching via Text
- OTHER E-Cigarette Cessation Materials
Study Locations (1)
Massachusetts
- UMass Chan Medical School - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2022-12-19 |
| Est. Completion | 2024-08-30 |
| Phase | NA |
What the finished NCT05140915 record still lists
NCT05140915 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 757-participant average among 18 other Vaping trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Vaping appearing as the primary indexed condition, and to 4 interventions - of which Gamification is the first listed.
NCT05140915 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05140915 about?
NCT05140915 is a clinical study titled "Vaper to Vaper: A Multimodal Mobile Peer Driven Intervention to Support Adolescents in Quitting Vaping". The dramatic increase in the use of e-cigarettes among U.S. adolescents has been called a national epidemic, with more adolescents now using e-cigarettes than traditional cigarettes. The high amounts of nicotine in e-cigarettes harm adolescents and put them at greater risk of becoming traditional ci...
What is the current status of trial NCT05140915?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2022-12-19. Estimated completion is 2024-08-30.
What conditions does trial NCT05140915 study?
This clinical trial studies the following conditions: Vaping, E-cigarette Use.
What interventions are being tested in trial NCT05140915?
The interventions under investigation include: Gamification (BEHAVIORAL), Peer Messaging (BEHAVIORAL), Peer Coaching via Text (BEHAVIORAL), E-Cigarette Cessation Materials (OTHER).
Who is sponsoring clinical trial NCT05140915?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05140915 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaping
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05140915's enrollment target sits among peer trials
71 14th of 18 higher than 5 of 18 other Vaping trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vaping trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study
RECRUITING · NA
-
Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults
RECRUITING · NA
-
Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol
RECRUITING · NA
-
Behavioral Intervention for Youth to Promote Vaping Cessation
RECRUITING · NA
-
Implementing an Adolescent and Young Adult (AYA) mHealth Vaping Cessation Program Into Oncology Clinics
RECRUITING · NA
-
Network Intervention to Prevent Vaping
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI